The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2017 | Using cell mass to determine response to treatment: A possible cure?
Nikhil Munshi, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses his keynote speech at the 2017 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France. Dr Munshi talks about the possibility of diagnosing myeloma and identifying specific subtypes using just circulating myeloma cells in the blood. There is a novel technology being developed that will measure the mass of cells when exposed to certain drugs, to see how many respond, and therefore accurately judge whether the patient would respond to treatment. There have also been promising results from recent CAR T-cell studies, showing outstanding responses even in patients with advanced disease. Dr Munshi states that there is hope to cure myeloma within the next few decades.
